Impacto da pandemia da COVID-19 sobre o tratamento medicamentoso dos pacientes com doença arterial periférica: um estudo observacional transversal
Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study
Heloisa Amaral Braghieri; Marília de Almeida Correia; Juliana Ferreira de Carvalho; Paulo Longano; Nelson Wolosker; Gabriel Grizzo Cucato; Raphael Mendes Ritti-Dias; Hélcio Kanegusuku
Background: The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population’s behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. Objectives: To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. Methods: In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnaire by telephone involving the following questions: a) precautions related to COVID-19; b) general health status; and c) treatment of diseases. Subsequently, patients were divided into two groups according to difficulty in obtaining their drugs (DOD: difficulty obtaining drugs, or NDOD: no difficulty obtaining drugs) and overall health was compared between groups. Results: Seventeen percent of patients reported difficulties with obtaining drugs during the pandemic. A higher proportion of these patients reported being sadder (56.5% vs. 24.8%, P < 0.01) and having more difficulty sleeping (56.5% vs. 24.8%, P < 0.01) than of the patients in the NDOD group (P 0.05). Conclusions: A higher proportion of patients in the DOD group reported being sadder and having greater difficulty sleeping compared to the NDOD group during the COVID-19 pandemic.
1 Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18(2):185-92.
2 Muir RL. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs. 2009;27(2):26-30.
3 Wolosker N, Rosoky RA, Nakano L, Basyches M, Puech-Leão P. Predictive value of the ankle-brachial index in the evaluation of intermittent claudication. Rev Hosp Clin Fac Med Sao Paulo. 2000;55(2):61-4.
4 Farah BQ, Souza Barbosa JP, Cucato GG, et al. Predictors of walking capacity in peripheral arterial disease patients. Clinics. 2013;68(4):537-41.
5 Brevetti G, Oliva G, Di Giacomo S, Bucur R, Annecchini R, Di Iorio A. Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease. J Am Geriatr Soc. 2001;49(9):1261-2.
6 Spronk S, White JV, Bosch JL, Hunink MG. Impact of claudication and its treatment on quality of life. Semin Vasc Surg. 2007;20(1):3-9.
7 Wolrd Health Organization [site na Internet]. Coronavirus disease (COVID-19) pandemic. 2021 [citado 26 jan 2021].
8 Peçanha T, Goessler KF, Roschel H, Gualano B. Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020;318(6):H1441-6.
9 Lofrano-Prado MC, Prado WL, Botero JP, et al. The same storm but not same the boat: Effects of COVID-19 stay-at-home order on mental health in individuals with overweight. Clin Obes. 2021;11(1):e12425.
10 Diniz TA, Christofaro DGD, Tebar WR, et al. Reduction of physical activity levels during the COVID-19 pandemic might negatively disturb sleep patern. Front Psychol. 2020;11:586157.
11 Coronado PJ, Fasero M, Otero B, et al. Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement. Maturitas. 2021;144:4-10.
12 Dopheide JF, Veit J, Ramadani H, et al. Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. Eur Heart J Cardiovasc Pharmacother. 2019. No prelo.
13 Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-909.
14 Khan A, Althunayyan S, Alsofayan Y, et al. Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia. East Mediterr Health J. 2020;26(11):1371-80.
15 Rezende LFM, Thome B, Schveitzer MC, Souza-Júnior PRB, Szwarcwald CL. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Rev Saude Publica. 2020;54:50.
16 Casares M, Khan H. The timing and intensity of social distancing to flatten the COVID-19 Curve: the case of Spain. Int J Environ Res Public Health. 2020;17(19):7283.
17 Hsiang S, Allen D, Annan-Phan S, et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820):262-7.
18 Coulthard H, Sharps M, Cunliffe L, van den Tol A. Eating in the lockdown the Covid 19 pandemic; self-reported changes in eating behaviour, and associations with BMI, eating style, coping and health anxiety. Appetite. 2021;161:105082.
19 Wang Q, Luo Y, Lv C, et al. Nonadherence to treatment and patient-reported outcomes of psoriasis during the COVID-19 epidemic: a web-based survey. Patient Prefer Adherence. 2020;14:1403-9.
20 Almeida Correia M, Andrade-Lima A, Mesquita de Oliveira PL, et al. Translation and Validation of the Brazilian-Portuguese Short Version of Vascular Quality of Life Questionnaire in Peripheral Artery Disease Patients with Intermittent Claudication Symptoms. Ann Vasc Surg. 2018;51:48-54.e1.
21 Maksimovic M, Vlajinac H, Marinkovic J, Kocev N, Voskresenski T, Radak D. Health-related quality of life among patients with peripheral arterial disease. Angiology. 2014;65(6):501-6.
22 Rich K. The connection between obstructive sleep apnea and peripheral artery disease. J Vasc Nurs. 2020;38(4):195-7.
23 Farah BQ, Ritti-Dias RM, Cucato GG, Montgomery PS, Gardner AW. Factors associated with sedentary behavior in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2016;52(6):809-14.
24 Li W, Chen X, Feng H. Impact of COVID-19 on peripheral arterial disease treatment. Ann Vasc Surg. 2020;67:6-7.